As your dynamic global partner for end-to-end biopharma services, we help you accelerate the development of novel therapies and get them to the patients who need them most.
We expedite biomarker-driven drug development from discovery to global CDx commercialization with our centralized and kitted genomic profiling assays, established clinical trial infrastructure and expert regulatory guidance. Now you can bring cutting-edge cancer therapies within reach for all to make the promise of precision medicine a reality.
We help you navigate each step of the process to shorten the path to CDx and minimize risk.
Advance your research and discovery efforts with our comprehensive and flexible testing portfolio of central lab services and kitted assays. We partner with you to ensure access to critical biomarker insights on a global scale.
Comprehensive + proven
Our comprehensive solid tumor profiling platform for both tissue and plasma samples, backed by proven bioinformatics, ensures you have access to the critical biomarker insights you need.
Global reach + scale
Our flexible testing portfolio of central lab services and kitted assays helps you reach patient cohorts around the globe and can accommodate large-scale retrospective studies.
Consultative approach
We are committed to providing tailored solutions that advance your research — from early access to emerging and complex biomarkers to custom data outputs.
Accelerate your path to commercialization with our established global testing infrastructure, expert regulatory guidance, and custom analysis and reporting designed to meet your needs.
Expert guidance
Leverage our deep companion diagnostic development expertise to navigate the regulatory landscape with confidence and accelerate your path to commercialization.
Global infrastructure
Our established global infrastructure offers both central lab services and kitted solutions to facilitate and scale your commercialization efforts.
Consultative approach
From retrospective analysis to custom clinical trial reporting, we are equipped and committed to provide tailored solutions that meet your needs.
We are committed to helping you advance your research with proven and cost-efficient CGP solutions, access to our latest technology innovations, and expert guidance every step of the way.
Fewer financial hurdles
We are dedicated to helping remove financial barriers to your research — from providing quick and cost-efficient CGP solutions to exploring collaborative cost sharing.
Proven performance
Our CGP solid tumor assays for both tissue and blood samples have demonstrated sensitive detection of current and emerging biomarkers and complex genomic signatures.
Expert collaboration
We are committed to your success, providing access to our latest technology innovations and a team of experts that can help you navigate each step of your research project.
Our solid tumor comprehensive genomic profiling (CGP) assays for both tissue and plasma samples are available as central lab services or kitted solutions.
*Refer to PGDx product insert for intended use statement and country availability
Thank you for your submission.
A PGDx representative will be in contact with you soon.